4.25 USD
↘ 0.03 (0.72%)LIVE (AS OF 10:07 AM EDT)
Cytek Biosciences, Inc. Common Stock (CTKB) is currently trading at $4.25. The technical outlook is "Strong Sell" and the fundamental picture shows "Neutral". This is driven by a robust Altman Z-Score, negative Return on Equity and a bearish Death Cross on the long-term moving averages. Valuation metrics suggest CTKB is trading at a discount to its peers, earning an "Attractively Valued" rating.
Technical & fundamental data as of Aug 4, 2026.